Evidence map›Paper›PMID 9573246›Full record

ArticleJournal of virology1998

Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

X S Wang, A Srivastava

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Reply to "D" matters in recombinant AAV packaging.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A genetic screen identifies a cellular regulator of adeno-associated virus.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

X S WangDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
A Srivastava
Walther Cancer Foundation · US

Funding

VectorP01HL053586 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI CLAPP, DAVID W · 1995 to 2009
$16.0M
PILOT AND FEASIBILITY STUDIESP30DK049218 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SROUR, EDWARD F · 1999 to 2004
$4.6M
PARVOVIRUS VECTORS FOR HUMAN GENE THERAPYR01HL058881 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SRIVASTAVA, ARUN · 1997 to 2002
$1.2M
GENETIC MODIFICATION/ALTERNATIVE SOURCES OF STEM CELLP50DK049218 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LIECHTY, EDWARD A · 1994 to 1998
–
PARVOVIRUS-MEDIATED GENE TRANSFER IN STEM CELLSR01HL048342 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SRIVASTAVA, ARUN · 1992 to 1996
–
NHLBI NIH HHS HL-48342NHLBI NIH HHS HL-53586NHLBI NIH HHS HL-58881NHLBI NIH HHS P01 HL053586NHLBI NIH HHS R01 HL058881NIDDK NIH HHS P30 DK049218NIDDK NIH HHS P50 DK049218
6 · The paper itself

Abstract

The Rep proteins encoded by the adeno-associated virus type 2 (AAV) play a crucial role in the rescue, replication, and integration of the viral genome. In the absence of a helper virus, little expression of the AAV Rep proteins occurs, and the AAV genome fails to undergo DNA replication. Since previous studies have established that expression of the Rep78 and Rep68 proteins from the viral p5 promoter is controlled by the Rep-binding site (RBS) and the YY1 factor-binding site (YBS), we constructed a number of recombinant AAV plasmids containing mutations and/or deletions of the RBS and the YBS in the p5 promoter. These plasmids were transfected in HeLa or 293 cells and analyzed for the potential to undergo AAV DNA rescue and replication. Our studies revealed that (i) a low-level rescue and autonomous replication of the wild-type AAV genome occurred in 293 but not in HeLa cells; (ii) mutations in the RBS resulted in augmented expression from the p5 promoter, leading to more efficient rescue and/or replication of the AAV genome in 293 but not in HeLa cells; (iii) little rescue and/or replication occurred from plasmids containing mutations in the YBS alone in the absence of coinfection with adenovirus; (iv) expression of the adenovirus E1A gene products was insufficient to mediate rescue and/or replication of the AAV genome in HeLa cells; (v) autonomously replicated AAV genomes in 293 cells were successfully encapsidated in mature progeny virions that were biologically active in secondary infection of HeLa cells in the presence of adenovirus; and (vi) stable transfection of recombinant AAV plasmids containing a gene for resistance to neomycin significantly affected stable integration only in 293 cells, presumably because rescue and autonomous replication of the AAV genome from these plasmids occurred in 293 cells but not in HeLa or KB cells. These data suggest that in the absence of adenovirus, the AAV Rep protein-RBS interaction plays a dominant role in down-regulating viral gene expression from the p5 promoter and that perturbation in this interaction is sufficient to confer autonomous replication competence to AAV in 293 cells.

Indexed as

DNA-Binding ProteinsGenome, ViralVirus ReplicationDependovirusDNA HelicasesGene Expression Regulation, ViralPlasmidsPromoter Regions, GeneticTrans-ActivatorsViral ProteinsDNA-Binding ProteinsDNA Helicasesreplication initiator proteinTrans-ActivatorsViral Proteins

Identifiers

PMID9573246
PMCPMC110022
OpenAlexW1606684379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.